Close
0
You have no items in your order cart.
Search
Filters

Antibiotics

View as Grid List
Sort by
Display per page

Acti-Tetra B - 1kg

118744
For chickens AR16 licence. Active ingredient: Oxytetracycline

Alamycin 20 LA - 100ml

105690
A long acting broad spectrum injectable antibiotic containing Oxytetracycline Dihydrate equivalent to 200 mg/ml of Oxytetracycline base. It is suitable for acute infections caused by organisms sensitive to oxytetracycline. Blood levels persist for at least 4 days. Indicated for use in cattle, sheep and pigs in the treatment of: atrophic rhinitis caused by Bordetella bronchiseptica, Pasteurella haemolytica and Pasteurella multocida; navel/joint ill caused by Corynebacterium pyogenes, E. coli, and Staphylococcus aureus; mastitis caused by Corynebacterium pyogenes, E. coli, Staphylococcus aureus, Streptococcus agalactiae, and Streptococcus uberis; metritis caused by E. coli and Streptococcus pyogenes; pasteurellosis and infections of the respiratory tract caused by Pasteurella haemolytica and Pasteurella multocida; septicaemia caused by Salmonella dublin and Streptococcus pyogenes; erysipelas caused by Erysipelothrix rhusiopathiae. Alamycin LA can also be used in the control of enzootic abortion in sheep. The recommended dosage rate is 20 mg/kg bodyweight (1 ml per 10 kg bodyweight) by deep intramuscular injection. The product is recommended for a single administration only. Maximum recommended dose at any one site: Cattle 20ml Pigs 10ml Sheep 5ml Piglets: 1 day 0.2ml 7 days 0.3ml 14 days 0.4ml 21 days 0.5ml over 21 days 1.0ml/10kg Withdrawals Cattle: Meat 41 days,Milk 8 days Sheep: Meat 24 days, Milk 7 days Pigs: Meat 20 days

Alamycin L.A. 300 - 100ml

104340
For the treatment and control of a wide range of common systemic, respiratory, urinary and local infections caused by oxytetracycline sensitive organisms. Specific indications for Alamycin LA 300 Solution for Injection 300mg/ml would therefore include: pasteurellosis, pneumonia, atrophic rhinitis, erysipelas, joint ill/navel ill, summer mastitis in cows, ovine keratoconjunctivitis (pinkeye) and the control of enzootic abortion in sheep. Administer by deep intramuscular injection to cattle, sheep and pigs. 300mg/ml can be administered at the standard dose of 20mg/kg in order to obtain 3 to 4 days duration of activity or at the high dose of 30mg/kg for prolonged duration of activity (i.e. activity maintained for 5 to 6 days). Withdrawals Meat: Animals must not be slaughtered for human consumption during treatment. 20mg/kg dose: Cattle and sheep may be slaughtered for human consumption only after 28 days from the last treatment. Pigs may be slaughtered for human consumption only after 14 days from the last treatment. 30mg/kg dose: Cattle may be slaughtered for human consumption only after 35 days from the last treatment. Sheep and pigs may be slaughtered for human consumption only after 28 days from the last treatment. Milk: Milk for human consumption must not be taken during treatment. Milk for human consumption may be taken from cows only after 8 days from the last treatment. Milk for human consumption may be taken from ewes only after 8 days from the last treatment.

Alamycin L.A. 300 - 250ml

112851
For the treatment and control of a wide range of common systemic, respiratory, urinary and local infections caused by oxytetracycline sensitive organisms. Specific indications for Alamycin LA 300 Solution for Injection 300mg/ml would therefore include: pasteurellosis, pneumonia, atrophic rhinitis, erysipelas, joint ill/navel ill, summer mastitis in cows, ovine keratoconjunctivitis (pinkeye) and the control of enzootic abortion in sheep. Administer by deep intramuscular injection to cattle, sheep and pigs. 300mg/ml can be administered at the standard dose of 20mg/kg in order to obtain 3 to 4 days duration of activity or at the high dose of 30mg/kg for prolonged duration of activity (i.e. activity maintained for 5 to 6 days). Withdrawals Meat: Animals must not be slaughtered for human consumption during treatment. 20mg/kg dose: Cattle and sheep may be slaughtered for human consumption only after 28 days from the last treatment. Pigs may be slaughtered for human consumption only after 14 days from the last treatment. 30mg/kg dose: Cattle may be slaughtered for human consumption only after 35 days from the last treatment. Sheep and pigs may be slaughtered for human consumption only after 28 days from the last treatment. Milk: Milk for human consumption must not be taken during treatment. Milk for human consumption may be taken from cows only after 8 days from the last treatment. Milk for human consumption may be taken from ewes only after 8 days from the last treatment.

Amoxibactin - 250mg - 251 pack

132614
For use in dogs for the treatment of primary and secondary infections of the airways, such as rhinitis caused by Pasteurella spp. and Streptococcus spp.,and bronchopneumonia caused by Pasteurella spp., Escherichia coli and Gram-positive cocci. Treatment of primary infections of the urogenital tract, such as pyelonephritis and infections of the lower urinary tract caused by Escherichia coli, Proteus spp. and Gram-positive cocci, endometritis caused by Escherichia coli, Streptococcus canis and Proteus spp.,and vaginitis as a result of mixed infections. Treatment of mastitis caused by Gram-positive cocci and Escherichia coli. Treatment of local skin infections caused by Streptococcus spp. Active substance: Amoxicillin

Amoxibactin - 500mg - 252 pack

132624
For use in dogs for the treatment of primary and secondary infections of the airways, such as rhinitis caused by Pasteurella spp. and Streptococcus spp.,and bronchopneumonia caused by Pasteurella spp., Escherichia coli and Gram-positive cocci. Treatment of primary infections of the urogenital tract, such as pyelonephritis and infections of the lower urinary tract caused by Escherichia coli, Proteus spp. and Gram-positive cocci, endometritis caused by Escherichia coli, Streptococcus canis and Proteus spp.,and vaginitis as a result of mixed infections. Treatment of mastitis caused by Gram-positive cocci and Escherichia coli. Treatment of local skin infections caused by Streptococcus spp. Active substance: Amoxicillin

Amoxibactin - 50mg - 250 pack

132604
For use in dogs for the treatment of primary and secondary infections of the airways, such as rhinitis caused by Pasteurella spp. and Streptococcus spp.,and bronchopneumonia caused by Pasteurella spp., Escherichia coli and Gram-positive cocci. Treatment of primary infections of the urogenital tract, such as pyelonephritis and infections of the lower urinary tract caused by Escherichia coli, Proteus spp. and Gram-positive cocci, endometritis caused by Escherichia coli, Streptococcus canis and Proteus spp.,and vaginitis as a result of mixed infections. Treatment of mastitis caused by Gram-positive cocci and Escherichia coli. Treatment of local skin infections caused by Streptococcus spp. Active substance: Amoxicillin

Amoxy Active 697 mg/g 1kg

156785
Pigs: For the treatment of respiratory tract infections, gastro-intestinal tract infections, urogenital infections, ear necrosis, secondary infections following viral infections and septicemia caused by micro-organisms susceptible to amoxicillin. Poultry: Treatment of respiratory tract infections and gastro-intestinal tract infections caused by micro-organisms susceptible top amoxicillin.

Amproline - 1lt

162074
In chickens (broilers, pullets, layers and breeder hens), turkeys: Treatment of intestinal coccidiosis caused by Eimeria spp susceptible to amprolium. Withdrawal periods Chickens and turkeys: - Meat and offal: zero days Eggs: zero days

Apoquel - 16mg - 100 pack

132234
Indicated for the treatment of pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis in dogs. Active ingredient: Oclacitinib Maleate

Apoquel - 16mg - 20 pack

132224
Indicated for the treatment of pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis in dogs. Active ingredient: Oclacitinib Maleate

Apoquel - 3.6mg - 100 pack

132194
Indicated for the treatment of pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis in dogs. Active ingredient: Oclacitinib Maleate
Close
Filter by Clear All